Home » Posts tagged with » TUKYSA
Seattle Genetics signs $4.4bn worth oncology deals with Merck
US biotech company Seattle Genetics has secured deals worth up to $4.4 billion with Merck, that include two new strategic oncology collaborations. The two major pharma companies will develop and commercialize Seattle Genetics’ ladiratuzumab vedotin across the world. Ladiratuzumab vedotin is an investigational antibody-drug conjugate (ADC) that targets LIV-1, which is presently in phase 2 […]
Business News Today
- Corbion, Total to build €200m PLA bioplastics plant in France
- iPipeline acquires Impact Financial Systems
- Nautilus Solar Energy acquires 17MW solar portfolio from Pine Gate Renewables
- Palladium Equity Partners acquires majority stake in Trachte USA from MPE Partners
- The Hilb Group acquires life and health agency Ganim Benefits in Connecticut
- La Brea Bakery to invest in automation processes at Van Nuys bakery
- REG begins construction on single wind turbine project in Minnesota
- Cube Highways acquires Farakka-Raiganj Highways from HCC
- ASG LegalTech acquires online legal payments platform Headnote
- Microsoft to acquire ZeniMax Media, owner of Bethesda Softworks
